 | Up a level |
Sanyal, Arun J; Chung, Chuhan; Myers, Robert P; Bosch, Jaime (2022). Reply. Hepatology, 76(1), E5-E6. Wiley 10.1002/hep.32373
Sanyal, Arun J; Anstee, Quentin M; Trauner, Michael; Lawitz, Eric J; Abdelmalek, Manal F; Ding, Dora; Han, Ling; Jia, Catherine; Huss, Ryan S; Chung, Chuhan; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Romero-Gomez, Manuel; Muir, Andrew J; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary; Harrison, Stephen A; Younossi, Zobair M and Myers, Robert P (2022). Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis. Hepatology, 75(5), pp. 1235-1246. Wiley 10.1002/hep.32204
Loomba, Rohit; Huang, Daniel Q.; Sanyal, Arun J; Anstee, Quentin Mark; Trauner, Michael; Lawitz, Eric J; Ding, Dora; Ma, Lily; Jia, Catherine; Billin, Andrew; Huss, Ryan S; Chung, Chuhan; Goodman, Zachary; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Romero-Gómez, Manuel; Abdelmalek, Manal F; Muir, Andrew; Afdhal, Nezam; Bosch, Jaime; ... (2022). Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut, 72(3), pp. 581-589. BMJ Publishing Group 10.1136/gutjnl-2022-327777
Bosch, Jaime; Chung, Chuhan; Carrasco-Zevallos, Oscar M; Harrison, Stephen A; Abdelmalek, Manal F; Shiffman, Mitchell L; Rockey, Don C; Shanis, Zahil; Juyal, Dinkar; Pokkalla, Harsha; Le, Quang Huy; Resnick, Murray; Montalto, Michael; Beck, Andrew H; Wapinski, Ilan; Han, Ling; Jia, Catherine; Goodman, Zachary; Afdhal, Nezam; Myers, Robert P; ... (2021). A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis. Hepatology, 74(6), pp. 3146-3160. Wiley 10.1002/hep.32087
Povero, Davide; Yamashita, Hirokazu; Ren, Wenhua; Subramanian, Mani G; Myers, Robert P; Eguchi, Akiko; Simonetto, Douglas A; Goodman, Zachary D; Harrison, Stephen A; Sanyal, Arun J; Bosch, Jaime; Feldstein, Ariel E (2020). Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH. Hepatology communications, 4(9), pp. 1263-1278. Wiley 10.1002/hep4.1556
Sanyal, Arun J; Harrison, Stephen A; Ratziu, Vlad; Abdelmalek, Manal F; Diehl, Anna Mae; Caldwell, Stephen; Shiffman, Mitchell L; Aguilar Schall, Raul; Jia, Catherine; McColgan, Bryan; Djedjos, C Stephen; McHutchison, John G; Subramanian, G Mani; Myers, Robert P; Younossi, Zobair; Muir, Andrew J; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary (2019). The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. Hepatology, 70(6), pp. 1913-1927. Wiley 10.1002/hep.30664
Younossi, Zobair; Stepanova, Maria; Sanyal, Arun J; Harrison, Stephen A; Ratziu, Vlad; Abdelmalek, Manal F; Diehl, Anna Mae; Caldwell, Stephen; Shiffman, Mitchell L; Schall, Raul Aguilar; McColgan, Bryan; Subramanian, G Mani; Myers, Robert P; Muir, Andrew; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary (2018). The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. Journal of hepatology, 69(6), pp. 1365-1370. Elsevier 10.1016/j.jhep.2018.08.013
Harrison, Stephen A; Abdelmalek, Manal F; Caldwell, Stephen; Shiffman, Mitchell L; Diehl, Anna Mae; Ghalib, Reem; Lawitz, Eric J; Rockey, Don C; Schall, Raul Aguilar; Jia, Catherine; McColgan, Bryan J; McHutchison, John G; Subramanian, G Mani; Myers, Robert P; Younossi, Zobair; Ratziu, Vlad; Muir, Andrew J; Afdhal, Nezam H; Goodman, Zachary; Bosch, Jaime; ... (2018). Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology, 155(4), pp. 1140-1153. Elsevier 10.1053/j.gastro.2018.07.006
